Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Usefulness of Adding Pre-procedural Glycemia to the Mehran Score to Enhance Its Ability to Predict Contrast-induced Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention Development and Validation of a Predictive Model.
Nusca A, Mangiacapra F, Sticchi A, Polizzi G, D'Acunto G, Ricottini E, Melfi R, Gallo P, Miglionico M, Giannone S, Ussia GP, Grigioni F. Nusca A, et al. Among authors: ricottini e. Am J Cardiol. 2021 Sep 15;155:16-22. doi: 10.1016/j.amjcard.2021.06.014. Epub 2021 Jul 17. Am J Cardiol. 2021. PMID: 34284868
Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study).
Patti G, Pasceri V, Vizzi V, Ricottini E, Di Sciascio G. Patti G, et al. Among authors: ricottini e. Am J Cardiol. 2011 Apr 1;107(7):995-1000. doi: 10.1016/j.amjcard.2010.11.025. Epub 2011 Jan 20. Am J Cardiol. 2011. PMID: 21256470
Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
Patti G, Ricottini E, Nusca A, Colonna G, Pasceri V, D'Ambrosio A, Montinaro A, Di Sciascio G. Patti G, et al. Among authors: ricottini e. Am J Cardiol. 2011 Jul 1;108(1):1-7. doi: 10.1016/j.amjcard.2011.03.001. Epub 2011 Apr 27. Am J Cardiol. 2011. PMID: 21529740 Clinical Trial.
A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) study.
Mangiacapra F, Patti G, Barbato E, Peace AJ, Ricottini E, Vizzi V, Gatto L, D'Ambrosio A, De Bruyne B, Wijns W, Di Sciascio G. Mangiacapra F, et al. Among authors: ricottini e. JACC Cardiovasc Interv. 2012 Mar;5(3):281-9. doi: 10.1016/j.jcin.2012.01.009. JACC Cardiovasc Interv. 2012. PMID: 22440493 Free article.
Strategies of clopidogrel load and atorvastatin reload to prevent ischemic cerebral events in patients undergoing protected carotid stenting. Results of the randomized ARMYDA-9 CAROTID (Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting) study.
Patti G, Tomai F, Melfi R, Ricottini E, Macrì M, Sedati P, Giardina A, Aurigemma C, Leporace M, D'Ambrosio A, Di Sciascio G. Patti G, et al. Among authors: ricottini e. J Am Coll Cardiol. 2013 Apr 2;61(13):1379-87. doi: 10.1016/j.jacc.2013.01.015. Epub 2013 Mar 9. J Am Coll Cardiol. 2013. PMID: 23490041 Free article. Clinical Trial.
Correlation of platelet reactivity and C-reactive protein levels to occurrence of peri-procedural myocardial infarction in patients undergoing percutaneous coronary intervention (from the ARMYDA-CRP study).
Patti G, Mangiacapra F, Ricottini E, Cannatà A, Cavallari I, Vizzi V, D'Ambrosio A, Dicuonzo G, Di Sciascio G. Patti G, et al. Among authors: ricottini e. Am J Cardiol. 2013 Jun 15;111(12):1739-44. doi: 10.1016/j.amjcard.2013.02.028. Epub 2013 Mar 26. Am J Cardiol. 2013. PMID: 23538022
Efficacy of clopidogrel reloading in patients with acute coronary syndrome undergoing percutaneous coronary intervention during chronic clopidogrel therapy (from the Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty [ARMYDA-8 RELOAD-ACS] trial).
Patti G, Pasceri V, Mangiacapra F, Colonna G, Vizzi V, Ricottini E, Montinaro A, D'Ambrosio A, Wijns W, Barbato E, Di Sciascio G; ARMYDA-8 RELOAD-ACS Investigators. Patti G, et al. Among authors: ricottini e. Am J Cardiol. 2013 Jul 15;112(2):162-8. doi: 10.1016/j.amjcard.2013.03.008. Epub 2013 Apr 18. Am J Cardiol. 2013. PMID: 23601577 Clinical Trial.
57 results